TrialInternational journal of clinical oncology2020

Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.

Warit Ruanglertboon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.